This phase I/II trial tests the safety, side effects and effectiveness of radioembolization with yttrium-90 (Y-90) in patients with early stage renal cell carc…

Stage I Renal Cell CancerStage II Renal Cell Cancer

~Estimated

~$10 – $6,250

Jonsson Comprehensive Cancer CenterNCT06432036

Phase 1

Prospective Study of Interstitial Brachytherapy for Unresectable/Unablatable T1b/T2a Renal Masses

This phase I/II trial investigates the side effects of interstitial brachytherapy and to see how well it works in limiting the growth of large kidney cancer ma…

Stage I Renal Cell CancerStage II Renal Cell Cancer

~Estimated

~$10 – $6,250

Jonsson Comprehensive Cancer CenterNCT04473781